Pharmacokinetics of sotalol during pregnancy

Summary

Sotalol, a beta-adrenoceptor blocking drug, was administered to 6 healthy pregnant volunteers between 32–36 weeks gestation and when at least 6 weeks post-partum. On both occasions, each volunteer was given sotalol 100 mg intravenously and 400 mg orally in randomised order with at least a 1 week washout period between. Plasma samples were analysed for sotalol using a fluorometric method and the pharmacokinetic profiles investigated. The systemic clearance of sotalol was significantly greater in the antenatal period (2.4±0.3 ml/min/kg) than in the post-natal phase (1.5±0.1 ml/min/kg). The apparent volume of distribution was similar in the two periods: the elimination half-life was 6.6±0.6h ante-natally and 9.3±0.7h post-natally after intravenous drug but the trend for faster elimination was not significant. The elimination half-life after oral administration (about 10h) and bioavailability (about 90%) were not altered significantly by pregnancy. It is suggested that the more rapid clearance of sotalol in pregnancy may be due to increases in renal plasma flow and glomerular filtration rate.

This is a preview of subscription content, log in to check access.

References

  1. Anttila M, Arstila M, Pfeffer M, Tikkanen R, Vallinkoski V, Sundquist H (1976) Human pharmacokinetics of sotalol. Acta Pharmacol Toxicol 39: 118–128

    Google Scholar 

  2. Berglund G, Descamps R, Thomas JA (1980) Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency. Eur J Clin Pharmacol 18: 321–326

    Google Scholar 

  3. Blair AD, Burgess ED, Maxwell BM, Cutler RE (1981) Sotalol kinetics in renal insufficiency. Clin Pharmacol Ther 29: 457–463

    Google Scholar 

  4. Brown HC, Carruthers SG, Kelly JG, McDevitt DG, Shanks RG (1976) Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol 9: 367–372

    Google Scholar 

  5. Davison JM, Hytten FE (1974) Glomerular filtration during and after pregnancy. Br J Obstet Gynaecol 81: 588–595

    Google Scholar 

  6. Dunlop W (1976) Investigations into the influence of posture on renal plasma flow and glomerular filtration rate during late pregnancy. Br J Obstet Gynaecol 83: 17–23

    Google Scholar 

  7. Frishman W (1979) Clinical pharmacology of the new beta-adrenergic blocking drugs. Part I. Pharmacodynamic and pharmacokinetic properties. Am Heart J 97: 663–670

    Google Scholar 

  8. Garrett ER, Schnelle K (1971) Separation and spectrofluorometric assay of beta-adrenergic blocker sotalol from blood and urine. J Pharm Sci 60: 833–839

    Google Scholar 

  9. Ishizaki T, Tawara K, Oriuchi K (1977) Project planning and evaluation of pharmacokinetics extrapolating from animal to man: A study using a beta-blocker, sotalol, as a model marker. Adv Clin Pharmacol 13: 265–282

    Google Scholar 

  10. Krauer B, Krauer F, Hytten FE (1980) Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol Ther 10: 301–328

    Google Scholar 

  11. Lewis PJ, DeSwiet M, Chamberlain GVP, Bulpitt CJ (1977) The management of hypertension in the pregnant woman. In: Lewis PJ (ed) Therapeutic problems in pregnancy. MTP Press. Lancaster, pp 53–62

    Google Scholar 

  12. McDevitt DG, Shanks RG (1977) Evaluation of once daily sotalol administration in man. Br J Clin Pharmacol 4: 153–156

    Google Scholar 

  13. O'Hare MF, Murnaghan GA, Russell CJ, Leahey WJ, Varma MPS, McDevitt DG (1980) Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol 87: 814–820

    Google Scholar 

  14. Philipson A (1977) Pharmacokinetics of ampicillin during pregnancy. J Infect Dis 136: 370–376

    Google Scholar 

  15. Sundquist H (1980) Basic review and comparison of beta-blocker pharmacokinetics. Curr Ther Res 28: 385–445

    Google Scholar 

  16. Tjandramaga TB, Thomas J, Verbeeck R, Verbesselt R, Verbenckmaens R, DeSchepper PJ (1976) The effect of endstage renal failure and haemodialysis of the elimination kinetics of sotalol. Br J Clin Pharmacol 3: 259–265

    Google Scholar 

  17. Truelove JF, Van Petten GR, Willes RF (1973) Action of several β-adrenoceptor blocking drugs in the pregnant sheep and fetus. Br J Pharmacol 47: 161–171

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

O'Hare, M.F., Leahey, W., Murnaghan, G.A. et al. Pharmacokinetics of sotalol during pregnancy. Eur J Clin Pharmacol 24, 521–524 (1983). https://doi.org/10.1007/BF00609896

Download citation

Key words

  • sotalol
  • beta-adrenoceptor antagonist
  • pregnancy
  • pharmacokinetics